THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 23 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $28,740,000 | +16.3% | 31,463 | +22.3% | 2.05% | +27.8% |
Q1 2022 | $24,712,000 | +2.1% | 25,735 | +2.6% | 1.61% | -14.9% |
Q4 2021 | $24,207,000 | +2.8% | 25,076 | -1.2% | 1.89% | -21.4% |
Q3 2021 | $23,544,000 | +24.6% | 25,388 | +28.0% | 2.40% | +37.3% |
Q2 2021 | $18,896,000 | +96.0% | 19,838 | +109.4% | 1.75% | +85.3% |
Q1 2021 | $9,639,000 | -24.4% | 9,473 | -99.9% | 0.94% | -45.8% |
Q4 2020 | $12,756,000 | +101.0% | 13,473,000 | +85.8% | 1.74% | +26.5% |
Q3 2020 | $6,345,000 | +276.6% | 7,250,000 | +314.3% | 1.38% | +110.5% |
Q2 2020 | $1,685,000 | -50.3% | 1,750,000 | -50.0% | 0.66% | -66.0% |
Q1 2020 | $3,391,000 | -56.9% | 3,500,000 | -53.3% | 1.92% | -51.1% |
Q4 2019 | $7,863,000 | +41.3% | 7,500,000 | +25.0% | 3.94% | +24.9% |
Q3 2019 | $5,565,000 | +7.9% | 6,000,000 | 0.0% | 3.15% | +5.4% |
Q2 2019 | $5,158,000 | -11.5% | 6,000,000 | 0.0% | 2.99% | -15.8% |
Q1 2019 | $5,827,000 | -13.1% | 6,000,000 | -7.7% | 3.55% | -6.2% |
Q4 2018 | $6,703,000 | -13.0% | 6,500,000 | 0.0% | 3.79% | -15.5% |
Q3 2018 | $7,702,000 | +40.9% | 6,500,000 | +18.2% | 4.48% | -4.7% |
Q2 2018 | $5,466,000 | +53.2% | 5,500,000 | +57.1% | 4.70% | +81.5% |
Q1 2018 | $3,567,000 | -7.2% | 3,500,000 | 0.0% | 2.59% | +13.4% |
Q4 2017 | $3,842,000 | -10.4% | 3,500,000 | 0.0% | 2.28% | -20.4% |
Q3 2017 | $4,288,000 | -9.4% | 3,500,000 | 0.0% | 2.87% | -14.8% |
Q2 2017 | $4,734,000 | +48.9% | 3,500,000 | +40.0% | 3.37% | +32.5% |
Q1 2017 | $3,180,000 | +83.8% | 2,500,000 | +66.7% | 2.54% | +34.1% |
Q4 2016 | $1,730,000 | – | 1,500,000 | – | 1.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 13,473,000 | $12,756,000 | 1.74% |
Shaolin Capital Management LLC | 14,065,000 | $13,281,000 | 0.93% |
ZAZOVE ASSOCIATES LLC | 3,773,000 | $3,584,000 | 0.44% |
FARALLON CAPITAL MANAGEMENT LLC | 56,695,000 | $53,806,000 | 0.32% |
Baupost Group | 30,000,000 | $28,396,000 | 0.26% |
Aequim Alternative Investments LP | 3,000,000 | $2,840,000 | 0.21% |
WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $22,817,000 | 0.17% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,257,000 | 0.15% |
SSI INVESTMENT MANAGEMENT LLC | 1,750,000 | $1,648,000 | 0.12% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 430,000 | $406,000 | 0.06% |